Citius Pharmaceuticals, Inc. Increase (Decrease) in Self Insurance Reserve
Citius Pharmaceuticals, Inc. (CTXR) reported Increase (Decrease) in Self Insurance Reserve of $315.12 thousand for the 9-month period ending 2017-06-30, per its 10-Q filed 2017-08-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInSelfInsuranceReserve · last filed 2017-08-14
- Citius Pharmaceuticals, Inc. increase (decrease) in self insurance reserve for the quarter ending 2017-06-30 was $136.00K.
- Citius Pharmaceuticals, Inc. increase (decrease) in self insurance reserve for the quarter ending 2017-03-31 was $71.86K.
- Citius Pharmaceuticals, Inc. increase (decrease) in self insurance reserve for the quarter ending 2016-12-31 was $107.25K.
- Citius Pharmaceuticals, Inc. increase (decrease) in self insurance reserve for the quarter ending 2016-09-30 was $128.25K.
- Citius Pharmaceuticals, Inc. increase (decrease) in self insurance reserve for fiscal 2016 was $288.25K.
| Period end | Increase (Decrease) in Self Insurance Reserve 3 month | Increase (Decrease) in Self Insurance Reserve 6 month | Increase (Decrease) in Self Insurance Reserve 9 month | Increase (Decrease) in Self Insurance Reserve 12 month |
|---|---|---|---|---|
| 2017-06-30 | $136.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-14 | $207.87K derived: sum of 2 quarters · filed 2017-08-14 | $315.12K 10-Q · filed 2017-08-14 | $443.37K derived: sum of 4 quarters · filed 2017-08-14 |
| 2017-03-31 | $71.86K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-15 | $179.12K 10-Q · filed 2017-05-15 | $307.37K derived: sum of 3 quarters · filed 2017-05-15 | |
| 2016-12-31 | $107.25K 10-Q · filed 2017-02-14 | $235.50K derived: sum of 2 quarters · filed 2017-02-14 | ||
| 2016-09-30 | $128.25K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-23 | $288.25K 10-K · filed 2016-12-23 | ||
| 2016-06-30 | $160.00K 10-Q · filed 2017-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |